Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NMBR antisense RNA 1 (NMBR-AS1; RP11-137J7.2) is a long non-coding antisense RNA transcribed from the reverse strand of the Neuromedin B receptor (NMBR) gene locus. Antisense lncRNAs like NMBR-AS1 do not encode proteins. Instead, they may regulate the expression of their sense, protein-coding partners through mechanisms such as chromatin modification, transcriptional interference, or mRNA stability. While some antisense lncRNAs have been implicated in the modulation of disease processes, there is currently no literature reporting established functions, disease relevance, or therapeutic targeting of NMBR-AS1 itself. NMBR-AS1 is not a receptor, enzyme, or therapeutic protein; rather, it is an example of a non-coding antisense transcript that may play regulatory roles at the RNA level. The entries you provided are accurate for a non-coding regulatory RNA, but it is not a conventional drug target. No specific biological functions, disease associations, or pharmacological interventions are documented for NMBR-AS1 in the core biomedical databases or scientific literature as of the current search.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NMBR antisense RNA 1 (NMBR-AS1).